Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lymphoma
Interventions: DRUG: aldesleukin|DRUG: filgrastim|DRUG: recombinant human stem cell factor|PROCEDURE: peripheral blood stem cell transplantation
Sponsor: Masonic Cancer Center, University of Minnesota
Collaborators: National Cancer Institute (NCI)